2007
DOI: 10.1016/j.fct.2006.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Risk assessment of triclosan [Irgasan®] in human breast milk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
109
2
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 188 publications
(115 citation statements)
references
References 20 publications
3
109
2
1
Order By: Relevance
“…Some studies suggest that the increased cancers (Keri et al, 2007), human health abnormalities (cardiovascular disease and diabetes) (Lang et al, 2008) and externalizing behaviors in 2-year-old children (especially among female children) can be associated with BPA exposure (Braun et al, 2009). Although in literature there are no clear evidence that suggests that TCS has adverse effects on humans (Dayan, 2007;Sullivan et al, 2003), the disruption of the thyroid hormone system raises concern on the potential endocrine disrupting effects of TCS and possible adverse effect on humans (Crofton et al, 2007;Zorrilla et al, 2009). …”
Section: Introductionmentioning
confidence: 97%
“…Some studies suggest that the increased cancers (Keri et al, 2007), human health abnormalities (cardiovascular disease and diabetes) (Lang et al, 2008) and externalizing behaviors in 2-year-old children (especially among female children) can be associated with BPA exposure (Braun et al, 2009). Although in literature there are no clear evidence that suggests that TCS has adverse effects on humans (Dayan, 2007;Sullivan et al, 2003), the disruption of the thyroid hormone system raises concern on the potential endocrine disrupting effects of TCS and possible adverse effect on humans (Crofton et al, 2007;Zorrilla et al, 2009). …”
Section: Introductionmentioning
confidence: 97%
“…These compounds are continually produced and are rapidly becoming prevalent at detectable concentrations: 1) environmentally in ground water and soil; and 2) in human blood, breast milk, and tissue (Hovander et al, 2002;Kolpin et al, 2002;Darbre, 2006;Dayan, 2006;Heidler et al, 2006;Nakada et al, 2006;Dayan, 2007). This knowledge has lead to growing public concern over the possible impacts on human health (Daughton and Ternes, 1999;Darbre, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Entonces un neonato puede estar expuestos a la absorción de TCS, lo que también obliga a preguntarse si existe un riesgo para el desarrollo del bebé debido a la ingesta del compuesto. Al respecto, en base a un cálculo de riesgo por exposición basado en la concentración de TCS en leche materna, se ha sugerido que la cantidad de TCS en leche materna no representa un riesgo para los infantes (31), sin embargo, el estudio sugiriendo esto fue facilitado por uno de los principales productores de TCS, sin especificar si existe conflicto de interés entre el autor y el productor (31).…”
Section: Triclosán En Humanosunclassified